These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35749461)

  • 1. Voting behavior during FDA Medical Device Advisory Committee panel meetings.
    Maisel-Campbell A; Schlessinger DI; Yanes AF; Veledar E; Reynolds KA; Ibrahim SA; Kang BY; Anvery N; Poon E; Alam M
    PLoS One; 2022; 17(6):e0267134. PubMed ID: 35749461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does seating location impact voting behavior on Food and Drug Administration advisory committees?
    Broniatowski DA; Magee CL
    Am J Ther; 2013; 20(5):502-6. PubMed ID: 21642834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.
    Tibau A; Ocana A; Anguera G; Seruga B; Templeton AJ; Barnadas A; Amir E
    JAMA Oncol; 2016 Jun; 2(6):744-50. PubMed ID: 26940233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021.
    Daval CJR; Teng TW; Russo M; Kesselheim AS
    JAMA Health Forum; 2023 Jul; 4(7):e231718. PubMed ID: 37418270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.
    Ciociola AA; Karlstadt RG; Pambianco DJ; Woods KL; Ehrenpreis ED;
    Am J Gastroenterol; 2014 Oct; 109(10):1508-12. PubMed ID: 25001252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting financial conflicts of interest in FDA advisory committees.
    Pham-Kanter G
    Milbank Q; 2014 Sep; 92(3):446-70. PubMed ID: 25199895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.
    Lurie P; Almeida CM; Stine N; Stine AR; Wolfe SM
    JAMA; 2006 Apr; 295(16):1921-8. PubMed ID: 16639051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unwanted Advice? Frequency, Characteristics, And Outcomes Of Negative Advisory Committee Votes For FDA-Approved Drugs.
    Daval CJR; Sarpatwari A; Kesselheim AS
    Health Aff (Millwood); 2022 May; 41(5):713-721. PubMed ID: 35500185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015.
    Zhang AD; Schwartz JL; Ross JS
    Milbank Q; 2019 Sep; 97(3):796-819. PubMed ID: 31304643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Product Approvability Recommendations From FDA Advisory Committees:: Inconsistently Sought, Indirectly Obtained.
    Gulfo JV; Briggeman J; Gamie A
    Ther Innov Regul Sci; 2018 Nov; 52(6):784-792. PubMed ID: 29714584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. United States Food and Drug Administration Advisory Committee outcomes and agency approval analysis from 2010 to 2015.
    McCormack Z
    J Am Pharm Assoc (2003); 2018; 58(5):530-533. PubMed ID: 30005816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and conflicts of interest at Food and Drug Administration Gastrointestinal Drug Advisory Committee meetings.
    Khan R; Elsolh K; Gimpaya N; Scaffidi MA; Bansal R; Grover SC
    PLoS One; 2021; 16(5):e0252155. PubMed ID: 34038480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory scripting: Stakeholder participation in food and drug administration medical device advisory meetings.
    White SK; Leiter V; Le MH; Helms CK
    PLoS One; 2023; 18(2):e0281774. PubMed ID: 36795788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity in Medical Device Clinical Trials: Do We Know What Works for Which Patients?
    Fox-Rawlings SR; Gottschalk LB; Doamekpor LA; Zuckerman DM
    Milbank Q; 2018 Sep; 96(3):499-529. PubMed ID: 30203600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declarations of interest by members of Health Canada's special advisory committees and panels: a descriptive study.
    Lexchin J
    CMAJ Open; 2019; 7(2):E334-E340. PubMed ID: 31110111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings.
    Hayes MJ; Prasad V
    Hastings Cent Rep; 2018 Mar; 48(2):10-13. PubMed ID: 29590518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings.
    Lurie P
    MedGenMed; 2006 Oct; 8(4):22. PubMed ID: 17415305
    [No Abstract]   [Full Text] [Related]  

  • 18. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study.
    Nguyen NT; Cook DM; Bero LA
    Clin Ther; 2006 Aug; 28(8):1231-1243. PubMed ID: 16982301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications.
    Lee SJ; Cho L; Klang E; Wall J; Rensi S; Glicksberg BS
    JAMA Netw Open; 2021 Jun; 4(6):e2112562. PubMed ID: 34156454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Appearance of Conflicts of Interest With Voting Behavior at FDA Advisory Committee Meetings-A Cross-sectional Study.
    Xu J; Emenanjo O; Ortwerth M; Lurie P
    JAMA Intern Med; 2017 Jul; 177(7):1038-1040. PubMed ID: 28464118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.